戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ye, develops depigmented patches, indicating retinal disorder.
2  a non-progressive, clinically heterogeneous retinal disorder.
3 represent an as-yet unidentified locus for a retinal disorder.
4 ficiency of CRX is not sufficient to cause a retinal disorder.
5 l CRISPR-based medicines for other inherited retinal disorders.
6 ons to treat RPE cell dysfunction in various retinal disorders.
7 nslation of similar compounds for ocular and retinal disorders.
8 lected cohort of individuals with hereditary retinal disorders.
9  targeting 105 genes implicated in inherited retinal disorders.
10 tinal tubulation (ORT) formation in advanced retinal disorders.
11 at promise for the treatment of degenerative retinal disorders.
12  transfer as a strategy for the treatment of retinal disorders.
13  Netherlands, a tertiary referral center for retinal disorders.
14 l diagnosis includes various optic nerve and retinal disorders.
15  underlying common pathology in degenerative retinal disorders.
16 17.45), respectively among cases with vitreo-retinal disorders.
17 ontribute to RPE cell death in both of these retinal disorders.
18  novel therapeutic strategy for treatment of retinal disorders.
19 r time-domain OCT (TD-OCT) in the imaging of retinal disorders.
20 vation of the choroid and RPE in age-related retinal disorders.
21 ith age and is particularly abundant in some retinal disorders.
22  treat patients with a variety of cancers or retinal disorders.
23 ment epithelial cells with aging and in some retinal disorders.
24 ome characteristics similar to human flecked retinal disorders.
25 e-related macular degeneration and ischaemic retinal disorders.
26 n the diagnosis of genetically heterogeneous retinal disorders.
27 .5%), retinal detachment (11% vs. 0.8%), and retinal disorder (28% vs. 2%) compared with controls.
28                                    Inherited retinal disorders and dry age-related macular degenerati
29 lied to any of the existing mouse models for retinal disorders and may be valuable for documenting im
30 rauma, infection and nutritional deficiency, retinal disorders, and other congenital abnormalities we
31 ath is the root cause of vision loss in many retinal disorders, and there is an unmet need for neurop
32 is the ultimate cause of vision loss in many retinal disorders, and there is an unmet need for neurop
33 le explanation would be that these different retinal disorders are caused by mutations in different g
34 herapeutic implications for the treatment of retinal disorders are discussed.
35                           Glaucoma and other retinal disorders are some of the major complications in
36 ession perturbations in pathogenesis of such retinal disorders as proliferative vitreoretinopathy and
37                       We describe a distinct retinal disorder, autosomal-recessive bestrophinopathy (
38 inisce about caring for patients with common retinal disorders before there was access to the diagnos
39 es a unique opportunity to gain insight into retinal disorders by enabling phenotypic correlation wit
40 enge to develop gene replacement therapy for retinal disorders caused by mutations in large genes, su
41 tosa (RP), a heterogenous group of inherited retinal disorder, causes slow progressive vision loss wi
42 tinal pigment epithelium, as seen in various retinal disorders, causes photoreceptor loss and subsequ
43 avimaculatus; FFM) is an autosomal recessive retinal disorder characterized by a juvenile-onset macul
44  Blue cone monochromacy (BCM) is an X-linked retinal disorder characterized by low vision, photoavers
45 nitis pigmentosa, is a progressive inherited retinal disorder characterized by photoreceptor cell dea
46 erred to as "rod monochromacy"), is a severe retinal disorder characterized clinically by an inabilit
47 cally and genetically heterogeneous group of retinal disorders characterized by nonprogressive impair
48 RPE, Krill's disease) is a rare inflammatory retinal disorder commonly affecting young adults.
49  (FEVR) is a nonsyndromic autosomal dominant retinal disorder commonly caused by variants in the FZD4
50 e NYX, which encodes nyctalopin, lead to the retinal disorder congenital stationary night blindness w
51 s diabetes mellitus and hypertension, vitreo-retinal disorders could be of future public health impor
52 atients from 13 families with CRX-associated retinal disorder (CRX-RD) were identified from 730 Japan
53 ated macular degeneration and most inherited retinal disorders culminate in the same final common pat
54 to develop novel prophylactic approaches for retinal disorders elicited by LBs.
55             Patients with ONH and congenital retinal disorders exhibited more severe visual acuity de
56                               The congenital retinal disorder group had no significant change in visu
57       One fourth of the subjects with vitreo-retinal disorder had low vision.
58 ment epithelial cells with aging and in some retinal disorders have been implicated in the etiology o
59 t spot where several phenotypically distinct retinal disorders have been mapped in the past year.
60                                     For many retinal disorders, however, targeting of therapeutic vec
61 e diseases, such as Rett syndrome, inherited retinal disorders, idiopathic pulmonary fibrosis, and Ch
62 uating the gene defects underlying inherited retinal disorders in dogs.
63 e a safe and effective strategy for treating retinal disorders in humans.
64           There are a few publications about retinal disorders in patients with myotonic dystrophy.
65                     The prevalence of vitreo-retinal disorders in this Nepalese population was 5.35%,
66 of pathologic processes in a wide variety of retinal disorders including monogenic retinal dystrophie
67 utcomes of anti-VEGF therapy for a number of retinal disorders, including neovascular age-related mac
68                                    Inherited retinal disorder (IRD) is a leading cause of blindness,
69 ted from a cohort of patients with inherited retinal disorders (IRDs) investigated at the National Re
70 ment of therapeutic strategies for inherited retinal disorders is a growing area of research.
71               However, the etiology of these retinal disorders is not well understood.
72 rying these mutant alleles when studying new retinal disorders is recommended.
73 nd molecular strategies to restore vision in retinal disorders, it remains unclear to what extent cen
74  Mutations in KCNJ13 are associated with two retinal disorders; Leber congenital amaurosis (LCA) and
75  an excellent candidate for several X-linked retinal disorders mapping within this interval.
76 erve hypoplasia (ONH; n = 23), or congenital retinal disorder (n = 36).
77 sed by epiretinal membrane (n = 44) or other retinal disorders (n = 6) were enrolled in this study, c
78 ify additional candidate genes for inherited retinal disorders, novel retina/pineal-expressed EST clu
79 adults (age > 50 years) without AMD or other retinal disorders (NV).
80 II/II children had an increased incidence of retinal disorders (odds ratio, 2.43 [95% CI, 1.66-3.56])
81 ssociated with a higher prevalence of vitreo-retinal disorders (P < 0.001).
82  listed in the Genomics England PanelApp R32 Retinal Disorders panel (version 3.24), which includes 4
83                Achromatopsia 2, an inherited retinal disorder resulting in attenuation or loss of con
84          What is the impact of the inherited retinal disorder, retinal degenerate (rd/rd), on the str
85 phenotypic similarities to the human flecked retinal disorder retinitis punctata albescens.
86 nal adverse events were identified using the retinal disorders Standardized Medical Dictionary for Re
87 portionately affected by high disease burden retinal disorders such as age-related macular degenerati
88 in a number of degenerative and inflammatory retinal disorders such as age-related macular degenerati
89 during aging, trauma, or during a variety of retinal disorders such as age-related macular degenerati
90  epithelium (RPE) is a hallmark of aging and retinal disorders such as Stargardt disease and age-rela
91        Diabetic retinopathy (DR) is a severe retinal disorder that can lead to vision loss, however,
92  blindness (CSNB) is an inherited stationary retinal disorder that is clinically and genetically hete
93                           Only one inherited retinal disorder, the enhanced S cone syndrome (ESCS), s
94 gy, and of managing various other peripheral retinal disorders to prevent retinal detachment (RD).
95 ry via the sclera is a promising approach to retinal disorder treatments that require access to the p
96 ce of low vision and blindness due to vitreo-retinal disorders was 1.53% (95% CI, 1.18 - 1.97) and 0.
97             The overall prevalence of vitreo-retinal disorders was 5.35% (95% CI, 4.67 - 6.09).
98  (LH) deficiency to lymphoma progression and retinal disorders, we study by mesoscale chromatin model
99           The population prevalence of other retinal disorders were hypertensive retinopathy 0.88%, m
100                                              Retinal disorders were the most common causes for admiss
101 th comorbidities that impact vision, such as retinal disorders, were excluded.
102      The flash ERG is most useful in diffuse retinal disorders, whereas the multifocal ERG is superio
103  to treat endothelial dysfunction in various retinal disorders, while minimizing potential adverse ef
104 related affected individuals, diagnosed with retinal disorders who underwent clinical ES.
105 egeneration (AMD) was the most common vitreo-retinal disorder with a prevalence of 1.50% (95% CI, 1.1
106                                  This unique retinal disorder with dual anomaly in visual processing
107 rogeneous group of non-progressive inherited retinal disorders with characteristic electroretinogram
108 ystrophy (IRD) is a broad group of inherited retinal disorders with heterogeneous genotypes and pheno
109 sults are relevant to clinically significant retinal disorders with vascular pathologies, including d

 
Page Top